Press Releases

Press Releases

June 2, 2022
ORIC Pharmaceuticals to Present at the Jefferies Healthcare Conference
May 17, 2022
ORIC Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference
May 9, 2022
ORIC Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Update
April 12, 2022
ORIC Pharmaceuticals Presents Promising Preclinical Data on Three Programs at the 2022 American Association for Cancer Research (AACR) Annual Meeting
March 21, 2022
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
March 17, 2022
ORIC Pharmaceuticals to Host Fourth Quarter and Full Year 2021 Financial Results and Operational Update Conference Call
March 8, 2022
ORIC Pharmaceuticals Announces Multiple Presentations at the 2022 American Association for Cancer Research (AACR) Annual Meeting
February 2, 2022
ORIC Pharmaceuticals to Participate in the Guggenheim 2022 Oncology Conference
January 25, 2022
ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 Amplifications
January 10, 2022
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones
Displaying 1 - 10 of 11